Go behind the scenes of LogiPharma USA 2026 with program director Charleen Ring and McKesson's Chris Van Norman in this Pharma Pulse special.
Commentary|Podcasts|August 26, 2024
The Capabilities of a 3PL Provider
Chris Williams expands on the services that a third-party logistics (3PL) partner should offer, while sharing ways to alleviate standard supply chain issues.
Advertisement
In this exclusive PC Podcast interview, Chris Williams, International Managing Director of Alloga Europe and ICS, discusses:
- What’s needed to support advanced therapy medicinal products from a temperature standpoint
- The current state of third-party logistics (3PLs) in Europe and what areas need to improve
- How expectations of pharma companies have changed in terms of what they expect a 3PL partner to provide
- How Alloga’s new facilities in Spain and the Netherlands fit within the company’s strategy
- What he believes 3PLs can do to support supply chains more efficiently
The latest episode of The Pharmaceutical Commerce Podcast is available directly on
Advertisement
Related to this article
In this week's Pharma Pulse, the EU Council adopts the "pharma package," Commerce details 0% tariffs for certain drugs and Sharp expands autoinjector assembly capacity.
In this week's Pharma Pulse, Vicapsys merges with Stateline, Veritiv targets GLP-1 shipping, Section 232 tariffs widen and HRSA's 340B rebate pilot deadline arrives.
Episode 3 of Supply Chain Signal examines the Aug. 31 MFN agreements with nine mid-size manufacturers, the GENEROUS Medicaid model and whether pricing, trade and manufacturing policy now add up to a new pharma operating model.
Cencora's Ameer Ali on the operational lift behind the 12-digit NDC shift, the readiness gap across manufacturers and what's at stake for product flow if systems aren't ready in time.
Temperature excursions cost pharma an estimated $35 billion a year as biologics, GLP-1s and cell and gene therapies raise cold chain stakes.
Informa's invitation-only Leadership Summit returns to CPHI Milan Oct. 6 as executives weigh sourcing, medicine security and reshoring pressure.
In this week's Pharma Pulse, Arkansas independent pharmacies bring an underpayment suit against Express Scripts, Novo Nordisk taps Anthropic for AI-driven drug discovery, and Sanofi, UCB and Opella join AstraZeneca on a supply chain heat decarbonization program.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
How the GLP-1 Boom Stress-Tests the Pharma Cold Chain
2
Why Waltz Health, Fresenius Kabi Are Taking Biosimilars Direct
3
Pharma Pulse: EU's Pharma Package and Specialty Drug Tariff Exemptions
4
GLP-1 Payment Risks: What Pharmacies Should Review with Their Processor
5